CVE-2024-0580: Omission of user-controlled key authorization in the IDMSistemas platform, affecting the QSige product
CVE-2024-0580 is a medium-severity flaw (CVSS 6.5) affecting sinergia. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Omission of user-controlled key authorization in the IDMSistemas platform, affecting the QSige product. This vulnerability allows an attacker to extract sensitive information from the API by making a request to the parameter '/qsige.locator/quotePrevious/centers/X', where X supports values 1,2,3, etc.
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 6.5 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | None |
| User interaction | Required |
| EPSS exploit chance | 0.5% (top 58%) |
| CISA exploited list | No |
| Weakness | CWE-639 |
| Published | 2024-01-18 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2024-0580?
sinergia: downgrade or apply the listed mitigation. Exact commands for each OS are on this page.
Is CVE-2024-0580 being exploited?
CVE-2024-0580 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2024-0580 affect?
CVE-2024-0580 affects sinergia. Severity is medium (CVSS 6.5). Omission of user-controlled key authorization in the IDMSistemas platform, affecting the QSige product. This vulnerability allows an attacker to extract sensitive information from the API by making a request to the parameter '/qsige.locator
How urgent is CVE-2024-0580?
Priority 33/100. No elevated risk signals yet.